Redbiotec competitorsClear all

Redbiotec's top competitors include Strata Oncology, Serotiny and Neogene Therapeutics.
Redbiotec
Redbiotec
Redbiotec is a biotech company that develops immunotherapies for cancer and herpes.
Strata Oncology
Strata Oncology
Strata Oncology is a precision oncology company enabling molecular indications for cancer therapeutics.
Serotiny
Serotiny
Serotiny is a company that is engaged in the discovery of proteins for cell therapies.
Neogene Therapeutics
Neogene Therapeutics
Neogene Therapeutics is a pre-clinical stage biotechnology company that develops a new class of personalized T cell therapies to treat cancer.
Founding Date
Founding Date
2006
Founding Date
2016
Founding Date
2014
Founding Date
2018
Type
Type
Private
Type
Private
Type
Private
Type
Private
Tags
Locations
Locations
Schlieren, CH HQ
Locations
Ann Arbor, US HQ
Locations
HQ
Locations
New York, US HQ
Amsterdam, NL
Employees
Employees
14
Employees
675% increase
Employees
10
Employees
4610% increase
Twitter followers
Twitter followers
124
Twitter followers
285
Twitter followers
64
Twitter followers
N/A
Employee Rating
Employee Rating
N/A
Employee Rating
4.4
Employee Rating
N/A
Employee Rating
N/A

Funding

Latest funding round
Latest funding round
N/A
Latest funding round
$ 26m (about 3 years ago)
Latest funding round
$ 3m (almost 3 years ago)
Latest funding round
$ 110m (9 months ago)
Total funding raised
Total funding raised
N/A
Total funding raised
$ 38m
Total funding raised
$ 3m
Total funding raised
$ 110m
For sources of this data, please see the company profile

View company profiles

Strata Oncology
HQ
Ann Arbor, US
Employees
67↑ 5% increase

Strata Oncology is a precision oncology company enabling molecular indications for cancer therapeutics.

View company
Serotiny
HQ
Employees
10

Serotiny is a company that is engaged in the discovery of proteins for cell therapies.

View company
Neogene Therapeutics
HQ
New York, US
Employees
46↑ 10% increase

Neogene Therapeutics is a pre-clinical stage biotechnology company that develops a new class of personalized T cell therapies to treat cancer.

View company